Table 2.
CS-based coatings | Material | Medical application | Species | Major conclusions | Reference |
---|---|---|---|---|---|
Antimicrobial agents | |||||
Rifampicin | CS filmsb,c | Long-term medical devices |
S. aureusf S. epidermidisf |
Bacterial cells were not able to grow on CS-rifampicin surfaces after 72 h incubation. | (Cao and Sun, 2009) d |
pH-responsive tobramycin-embedded micelles | Polydopamine-modified titanium surfacesb | Orthopedic implants |
E. colig S. aureusf |
Adhered bacteria were significantly lower (p< 0.05) on CS-tobramycin-coated surfaces than on the control group at 4 (1.18%), 12 (0.16%), 24 (0.25%), and 48 h (0.23%). | (Zhou et al., 2018) e |
Amoxicillin/clavulanic acid (CoAM) | Siliconeb,c | Tympanostomy tubes | S. aureusf | CS-CoAM-coated silicone films exhibited a high efficacy (> 93%) in the prevention of biofilm formation on the tube surface. | (Ajdnik et al., 2019) |
Disinfectant agents | |||||
Hyaloronic acid (HA)/triclosan | Modified titanium surfacesb,c | Medical implants | S. aureusf | Bacteria adhered to CS-HA surfaces lost their viability by 72%, while bacteria attached to the CS-HA/triclosan-coated surface showed a total loss in viability. | (Valverde et al., 2019) d |
Enzymes | |||||
Lysozyme | Stainless steel surfacesb | Medical implants and devices | S. aureusf | S. aureus viability decreased by more than 70% after 2h incubation with CS-lysozyme coatings, and > 95% after 4 h. | (Yuan et al., 2013) d |
Proteases | NDb | Indwelling medical devices |
L. monocytogenesh P. aeruginosai S. aureusf |
The antibiofilm activity of proteases was observed after 24 h of incubation; bead mobility was increased with Protease B (36%), Alcalase (57%), and Neutrase (84%). | (Elchinger et al., 2015) e |
Cellobiose dehydrogenase (CDH) and deoxyribonuclease I (DNase) | Polystyrene microtiter platesb | Indwelling medical devices |
C. albicansj S. aureusf |
Biofilms of S. aureus, C.albicans, or mixed species were inhibited by CS nanoparticles-DNase-CDH by 99%, 89%, and 91%, respectively. In addition, these composites caused 80% biofilm disruption on mono- and polymicrobial biofilms. | (Tan et al., 2020)n.d. |
Antimicrobial peptides (AMP) | |||||
Hyaluronic acid (HA)/β-peptide (coumarin-linker-(ACHC-B3hVal-B3hLys)3 | Polyethylene cathetersa,b | Central venous catheters | C. albicansj |
In vitrostudies: Biofilms formed on CS-HA-coated catheters reduced their metabolic activity by 80% compared to control. Catheter loading with β-peptide resulted in substantial reductions in biofilm growth (≈10%). In vivostudies: Biofilms formed on CS-HA-coated catheters were less robust than those observed on bare catheters. Tubes coated with β-peptide-loaded CS-HA films exhibited either no or very few yeast cells. |
(Raman et al., 2016) e |
Titanium surfacesb | Orthopedic implants | S. aureusf | Results demonstrated that coatings loaded with β-peptide prevented the formation of S. aureus biofilms for up to 24 days. After 36 days, biofilm viability reduced 60% compared to bare titanium. | (López et al., 2019) | |
α-helical AMP MSI-78(4-20) (KFLKKAKKFGKAFVKIL) | Gold substratesb | Bone implants and other medical devices | S. epidermidisf | The AMP-chitosan coating did not significantly reduce bacterial adhesion but decreased the viability of adhered cells by 60%. | (Monteiro et al., 2020) |
n.d., not described.
in vivo study.
in vitro study.
study performed under hydrodynamic conditions.
dip coating.
layer-by-layer assembly.
Staphylococcus sp.
Escherichia sp.
Listeria sp.
Pseudomonas sp.
Candida sp.